Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Sanofi, Regeneron Pharma bag USFDA nod for Kevzara to treat polymyalgia rheumatica

Ruchika Sharma2 March 2023 1:15 PM IST

Polymyalgia rheumatica often initially presents with pain and stiffness around the neck, shoulder and hip area and symptoms include fatigue, low-grade...

Flash fire at pharma unit in Hyderabad, 2 workers died

Ruchika Sharma2 March 2023 12:30 PM IST

Hyderabad: Two young workers, including a chemist, died in a flash fire while cleaning a reactor at a pharmaceutical company in Jeedimetla area here...

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA

Indoco Remedies receives 4 USFDA observations for Goa facilities

Ruchika Sharma2 March 2023 11:29 AM IST

Mumbai: Indoco Remedies Limited has announced that the United States Food and Drug Administration (USFDA) has issued four observations...

Lupin secures SBTi validation for emission reduction targets

Lupin Diagnostics unveils new Regional Reference Laboratory in Hyderabad

Ruchika Sharma1 March 2023 5:15 PM IST

Hyderabad: Global pharma major Lupin Limited announced today the launch of its new Regional Reference Laboratory in Hyderabad, Telangana."This...

Govt plans mega outreach programme to commemorate five years of Jan Aushadhi scheme

Ruchika Sharma1 March 2023 4:15 PM IST

Medicines available under PMBJP are priced 50-90 percent less than that of branded prices, source said.

Alembic Pharma secures USFDA approval for Travoprost Ophthalmic Solution

USFDA approves Alembic Pharma anti-cancer injection Docetaxel

Ruchika Sharma1 March 2023 3:12 PM IST

Docetaxel Injections are indicated for the breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcinoma and...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck scraps another prostate cancer study as Keytruda therapy disappoints

Ruchika Sharma1 March 2023 2:15 PM IST

New Delhi: Merck & Co said on Tuesday it will stop a late-stage trial evaluating a combination therapy with its cancer drug Keytruda after interim...

Zydus Lifesciences Hypertension drug gets USFDA okay

Ruchika Sharma1 March 2023 1:15 PM IST

The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.

Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada

Ruchika Sharma1 March 2023 12:15 PM IST

Multiple myeloma, commonly referred to as myeloma, is a cancer of plasma cells.

Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived

Zydus Lifesciences bags USFDA nod for Apixaban Tablets to treat blood clots in veins of legs or lungs

Ruchika Sharma1 March 2023 11:17 AM IST

The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad.

Two Maiden Pharma execs sentenced to two-and-half years jail for exporting substandard drugs to Vietnam

Ruchika Sharma28 Feb 2023 3:54 PM IST

A court in Sonipat, near New Delhi, where Maiden has its main production facility, ordered jail for company founder Naresh Kumar Goel and technical...

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

AbbVie gets positive EMA committee opinion for Upadacitinib to treat adults with moderate to severe Crohn's disease

Ruchika Sharma28 Feb 2023 1:30 PM IST

Discovered and developed by AbbVie scientists, upadacitinib is a selective and reversible Janus Kinase (JAK) inhibitor.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok